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Venous disorder is common in the general population. Uncomplicated varicose veins represent
a signiﬁcant proportion of the disease burden, and can impact considerably on quality of life, producing
a wide spectrum of symptoms. Little is known about the natural course of the disease at this stage and
the treatment strategy employed is often not based on robust scientiﬁc evidence.
The aim of this article is to elucidate the options to manage uncomplicated varicose veins. There are
likely to be signiﬁcant geographic differences in the treatment strategy employed, and it is hoped that we
will arouse discussion among physicians regarding the management of this very common medical
condition. The reader will be asked for their preferred treatment choice for a given clinical case vignette.
 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Background
Venous disorders affect a large proportion of the adult pop-
ulation, and are both commonly encountered in primary care and
frequently referred to hospital services.1 It encompasses a spectrum
of diseases, and there are a number of treatment options available,
which are likely to be variably practised. The aim of this article is to
evaluate current strategies in the management of uncomplicated
varicose veins, which represents a signiﬁcant portion of this
condition, in the context of the available evidence.
Recommendations for the treatment of patients with varicose
veins should be based on an understanding of the natural history of
the condition at this stage, taking into account the likely conse-
quences of leaving the disease untreated and the beneﬁts and risks
of any treatments. Conservative and invasive treatment options are
available and should be applied taking into account the impact of
disease progression, quality of life and health-care resources. In the
early disease stages Clear scientiﬁc evidence is lacking for one or
another management option. Therefore, differences in disease
awareness and treatment approaches are subject to an animated
discussion amongst specialists.rtment of Vascular Surgery,
þ44 2033117320; fax: þ44
vies).
ciety for Vascular Surgery. PublishFollowing reading the clinical vignette, you will be asked to
select your preferred management option from a list of three
choices.
Case Vignette
A 48-year-old woman was seen by her general practitioner
(primary care physician) for a routine examination. He refers the
patient to you for your specialist opinion on ‘some varicosity’ on the
left leg. The patient has a past medical history of hypothyroidism
for which she takes thyroxin 50 mcg daily. She drinks alcohol rarely
and does not smoke.
She is overweight, with a body mass index of 28. Her blood
pressure is 130/85 mmHg, and heart rate is 84 beats per minute.
Cardiovascular examination is normal. Examination of the legs
demonstrates left leg varicosities along the distribution of the great
saphenous vein. There are no associated skin changes and no
oedema can be detected at this time of the day (10 am).
On questioning, the patient does not report any history of leg
trauma, deep vein thrombosis or superﬁcial thrombophlebitis. Her
mother suffered from varicose veins without progression to severe
skin changes or venous ulceration. She ﬁrst noticed her left leg
varicose veins after her ﬁrst pregnancy. They increased in promi-
nence during her second pregnancy at the age of 39, but subse-
quently have remained unchanged. When asked speciﬁcally, she
conﬁrms that she experiences symptoms of heaviness in the left leg,
which is worse in the evening and during hot summer days. She alsoed by Elsevier Ltd. All rights reserved.
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previously investigated or received treatment for her varicose veins.
The patient following referral to you undergoes a duplex scan,
which reveals primary varicose veins with incompetence of the left
saphenoefemoral junction and long saphenous vein down to the
proximal calf region and two tributaries. The deep venous system is
normal and competent.
Which one of the following management strategies, any of
which would be considered correct, would you employ for this
patient? Please base your choice on your routine clinical practice.
a) No further diagnostic work-up or treatment. Follow-up at
routine visits with the GP once a year. No special treatment
recommendations.
b) Recommend the use of compression stockings (e.g.,
20e30mmHg) during work and periods of prolonged standing.
c) Ask the patient for her preferences, explain the evidence for the
natural course of the disease and for the various treatment
options and decide according to patient’s preference.
d) Consider ablative treatment for varicose veins, only if there is
secured funding.
e) Clear statement for varicose vein ablation. Treatment is indi-
cated to prevent further evolution of venous disorder in this
relatively young and otherwise healthy subject.
Comment on Case Vignette
In the case presented, the patient has clinical stage C2 according
to the clinical classiﬁcation of the Clinical Etiology Anatomical
Pathological (CEAP) system.2 Duplex scan reveals a primary vari-
cosity with complete incompetence of the long saphenous vein
down to the proximal calf level giving rise to two tributaries. The
deep venous system is normal and competent.
This is a commonly encountered situation and any interven-
tional treatment, given the above, might be considered to be fairly
controversial in this patient, as there are no signiﬁcant skin changes
and apparently no substantial reduction of quality of life. Conser-
vative and invasive treatment options will be brieﬂy presented
below. However, according to the latest recommendation of the
Venous Forum of the Royal Society of Medicine, ablative treatment
at this stage of disease should be considered, but is not compul-
sory.3 A slightly more aggressive stance is advocated in the recent
Clinical Practice Guidelines of the Society for Vascular Surgery and
the American Venous Forum. Based on grade 1B evidence (best
estimates of the critical beneﬁts and risks outcome from rando-
mised, controlled trials with important limitations), they advise
against compression therapy as a ﬁrst line approach, and recom-
mend endothermal saphenous vein ablation as the primary treat-
ment of symptomatic varicose veins in those patients who are
suitable for therapy.4
Treatment Options for Varicose Veins
Conservative treatment
Compression therapy forms the cornerstone of conservative
treatment for venous disorders independent of the underlying
cause.5 If no invasive or ablative treatment is being contemplated, it
can be suggested even without diagnostic work-up, in the absence
of signiﬁcant peripheral vascular disease. A calf-long medical
compression stockingwith adeﬁnedankle pressureof 20e30mmHg,
that is, class II compression hosiery is usually adequate. However, the
data available suggest that compliance to compression therapy is
generally poor.6 Moreover, given the relatively young age of the
patient, who is also likely to be in good health, lifelong medicalcompression therapy is unlikely to be considered to be an accept-
able option by the patient and indeed is unlikely to be cost effective.
Anti-oedema drugs, for example, horse-chestnut-seed extracts,
hydroxyethylrutosides, (Daﬂon) and red-vine-leaf extract AS195
(Antistax), have been shown to be efﬁcacious in the treatment of
venous symptoms in previous trials and should be considered.7e10
However, their long-term impact on disease progression and skin
changes is unknown. Other conservativemeasures, such as lifestyle
changes, have not been shown to offer any long-term preventative
or beneﬁcial effect in the presented case vignette.
Invasive treatment
Nowadays, there are a number of treatment options available for
ablation of varicose veins.11e14 Surgery was previously considered
to be the gold standard, but is now sidelined by less invasive
techniques, such as, endothermal procedures, for example, laser or
radiofrequency ablation and ultrasound guided foam scle-
rotherapy.11e14 These treatment modalities can be performed in an
outpatient setting under local anaesthesia, and their use is guided
and dependent on the anatomic/physiological ﬁndings on duplex.
Patient co-morbidities, skill of the treating specialist, local
health-care system proprieties and patient preference are all
factors that will inﬂuence the therapeutic modality applied. Short-
and mid-term results for endothermal ablation are promising and
have led to their routine use in many centres. Severe adverse events
appear to be very rare with both endothermal ablation and foam
sclerotherapy.11e14
Conclusion
This case vignette presents a commonly encountered situation
for the venous specialist. Different treatment options, any of each to
be considered correct, can be applied. More long-term data of
randomised controlled trials are needed to tailor the management
of uncomplicated varicose veins.
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